Rytus Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 6.25 Cr
as on 08-07-2024
- Paid Up Capital ₹ 6.21 Cr
as on 08-07-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.85 Cr
as on 08-07-2024
- Revenue 62.76%
(FY 2015)
- Profit 35.29%
(FY 2015)
- Ebitda 49.11%
(FY 2015)
- Net Worth -251.16%
(FY 2015)
- Total Assets -20.30%
(FY 2015)
About Rytus Therapeutics
- CIN/LLPIN
U24100MH2011PLC213828
- Company No.
213828
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rytus Therapeutics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Swaroop  | Whole-Time Director | 21-Feb-2011 | Current |
| Abhinna Sundar | Director | 21-Feb-2011 | Current |
| Manas Patnaik | Additional Director | 01-Dec-2021 | Current |
Financial Performance of Rytus Therapeutics.
Rytus Therapeutics Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 62.76% increase. The company also saw a substantial improvement in profitability, with a 35.29% increase in profit. The company's net worth observed a substantial decline by a decrease of 251.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rytus Therapeutics?
In 2015, Rytus Therapeutics had a promoter holding of 41.43% and a public holding of 58.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rytus Healthcare FoundationActive 13 years 6 monthsAbhinna Sundar and Anand Swaroop are mutual person
- Ssb Seva Kartavya FoundationActive 10 years 6 months
Abhinna Sundar and Anand Swaroop are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Feb 2013 | ₹1.10 Cr | Satisfied |
Tamilnad Mercantile Bank Limited Creation Date: 05 Oct 2011 | ₹7.50 M | Satisfied |
How Many Employees Work at Rytus Therapeutics?
Unlock and access historical data on people associated with Rytus Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rytus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rytus Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
